Speakers

Matt Drever

Vice President, Molecular Biology & Protein Engineering

Arsenal Biosciences

Andrew Phillips

Director, Bioinformatics & Biologics Engineering

AstraZeneca

Mark Kotter

Founder & Chief Executive Officer

bit.bio

Edward Green

Founder & Chief Scientific Advisor

CHAIN Biotechnology

Adam Silverman

Senior Director, Therapeutic Discovery

Codexis

Marc Güell

Co-Founder & Scientific Lead

Integra Therapeutics

Qi Cai

Director, Cell Biology

Kite Pharma: A Gilead Company

Wenning Qin

Senior Vice President, Research

eGenesis Inc.

Héctor Garcia Martin

Staff Scientist

Lawrence Berkeley National Laboratory

Lee Cooper

Senior Director, Venture Investments

Leaps by Bayer

Michael Hudson

Director, Synthetic Biology

LifeMine Therapeutics

Ron Weiss

Professor

Massachusetts Institute of Technology

Grant Murphy

Executive Director, Discovery Biologics

Merck & Co.

Lauren Popov

Director, Translational Biology

Novome Biotechnologies

Samuel Schaffter

Bioengineer

National Institute of Standards & Technology

Tariq Warsi

Head of Technical Operations

Novome Biotechnologies

Jaspreet Khurana

Director, Platform & Discovery

Strand Therapeutics

Jonathan Winkler

Senior Director, Analytical Development

Seres Therapeutics

Tim Lu

Co-Founder & Chief Executive Officer

Senti Biosciences

Yu Qiu

Digital Biologics Advanced Application Lead

Sanofi

Anders Lund

Head of Analytical Development

Synlogic

Dave Hava

Chief Scientific Officer

Synlogic

David James

Chief Scientific Officer

SynGenSys

Jake Becraft

Co-Founder & Chief Executive Officer

Strand Therapeutics

Maria Soloveychik

Co-Founder & Chief Executive Officer

SyntheX

Ruben Vasquez-Uribe

Co-Principal Investigator of the Bacterial Synthetic Biology Section

The Novo Nordisk Foundation Center for Biosustainability